Search - tctmd.com

Displaying 501 - 520 of 1656

Sort: Relevancy | Date

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Industry News

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

September 28, 2015

News Daily News

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

September 24, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

News Industry News

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

September 23, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Industry News

Early Patient Cases with Mitra-Spacer™ System presented at PCR London Valves 2015

September 21, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Daily News

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

September 17, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

September 15, 2015

News Daily News

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

September 15, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Daily News

Short-term Readmission Rates Similar After TAVR vs SAVR

Todd Neale

September 10, 2015

News Daily News

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

September 09, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

September 09, 2015

News Daily News

ProGlide Supera a Prostar XL en el Cierre del Sitio de Acceso para la TAVR Transfemoral

September 09, 2015

Advertisement

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

Early Patient Cases with Mitra-Spacer™ System presented at PCR London Valves 2015

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Ventrix Initiates Clinical Trial of VentriGel™

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

Registry Charts Trends in Mechanical Circulatory Support During PCI

Short-term Readmission Rates Similar After TAVR vs SAVR

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

ProGlide Supera a Prostar XL en el Cierre del Sitio de Acceso para la TAVR Transfemoral

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content